Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens

Eur J Pharmacol. 2004 Mar 8;487(1-3):55-63. doi: 10.1016/j.ejphar.2004.01.028.

Abstract

Histaprodifens constitute a new class of histamine H(1)-receptor agonists. These ligands can be regarded as hybrid molecules, consisting of a histamine moiety linked at the two-position of the imidazole ring by a propyl chain to two phenyl rings, one of the characteristic features of several H(1)-receptor antagonists. To delineate the binding site of various histaprodifen-like ligands, we generated mutant histamine H(1) receptors, in which various amino acids, involved in the binding of either histamine or H(1)-receptor antagonists, were replaced by alanine. Wild-type and mutant H(1) receptors were transiently expressed in African green monkey kidney cells (COS-7) and evaluated for their interaction with histamine and various histaprodifens by [(3)H]mepyramine radioligand-binding studies and by nuclear factor kappaB (NF-kappaB) reporter-gene assays. Our data show that, within the histamine H(1)-receptor binding pocket, histaprodifens interact with both agonist and antagonist binding sites, resulting in high affinity histamine H(1)-receptor agonists.

MeSH terms

  • Animals
  • Binding Sites / drug effects
  • COS Cells
  • Cells, Cultured
  • Chlorocebus aethiops
  • DNA Mutational Analysis*
  • Dose-Response Relationship, Drug
  • Genes, Reporter / genetics
  • Histamine / analogs & derivatives*
  • Histamine / metabolism*
  • Histamine Agonists / pharmacology*
  • Mutagenesis, Site-Directed
  • NF-kappa B / genetics
  • Pyrilamine / pharmacology
  • Receptors, Histamine H1 / genetics*
  • Receptors, Histamine H1 / metabolism*
  • Transfection

Substances

  • Histamine Agonists
  • NF-kappa B
  • Receptors, Histamine H1
  • histaprodifen
  • Histamine
  • Pyrilamine